Welcome/Opening Remarks

Oct 8, 2021 6:35am ‐ Oct 8, 2021 6:45am

Identification: A-2


Joe Harmon Memorial Lecture: Recognizing and Referring Patients for Advanced Heart Failure Therapies

Oct 8, 2021 6:45am ‐ Oct 8, 2021 7:45am

Identification: A-3

Learning Objective:
  • 1. The provider will be able to use both objective and subjective data when assessing their patient, in order to discern when someone should be referred for Adv HF Evaluation. 2. The care providers will know what testing to order to help determine what stage of HF their patient is in and be able to interrogate the results. 3. The participant will be able to recognize the options available to patients who have stage D HF or are nearing that point.

Cardiorenal Syndrome From the Nephrologist’s View Point

Oct 8, 2021 7:45am ‐ Oct 8, 2021 8:15am

Identification: A-4

In this presentation, we will explore explore the vast array of interrelated derangements and to stress the bi-directional nature of the heart kidney interaction.
Learning Objective:
  • 1. The Provider will understand the factors/lab testing that signify Cardio-renal syndrome. 2. The Provider will understand the treatments and methods to try to counteract Cardio-renal syndrome.

Basic Hemodynamics

Oct 8, 2021 8:15am ‐ Oct 8, 2021 8:45am

Identification: A-5

Learning Objective:
  • 1. The participant will be able to recognize the normal pressure ranges and blood flow in the heart. 2. The participant will be able to use hemodynamics to determine the appropriate therapy for a heart failure patient.

PHTN (RV failure)

Oct 8, 2021 9:00am ‐ Oct 8, 2021 9:30am

Identification: A-7

Learning Objective:
  • 1. The participant will be able to recognize the WHO classes of PHTN. 2. The participant will be able to recognize the hemodynamics that discern PAH from PVH.

Ambulatory Advanced Heart Failure

Oct 8, 2021 9:30am ‐ Oct 8, 2021 10:00am

Identification: A-8

This session will address the management of out-patients with advance heart failure who who are not eligible for advanced therapies. Pharmacologic and other approaches to care will be discussed.
Learning Objective:
  • 1. The participate will describe a step-by-step approach to diuretic escalation in a patient with advanced heart failure who demonstrates fluid retention and diuretic resistance. 2. The participate will be able to list 3 or more non-pharmacologic interventions for the management of patients with advanced heart failure. 3. The participant will identify high risk parameters which would prompt a referral to hospice in a patient with advanced heart failure, ineligible for surgical interventions.

Panel with Difficult Cases

Oct 8, 2021 10:00am ‐ Oct 8, 2021 10:45am

Identification: A-9

Learning Objective:
  • 1. Provide examples of patients with end-stage heart failure warranting evaluation for advanced therapies. 2. Discuss relative versus absolute contraindications for LVAD therapy and heart transplant through these examples.

Industry Presentation Sponsored by Abbott Utilizing CardioMEMS™ HF System to Trigger Advanced Heart Failure Evaluation

Oct 8, 2021 11:15am ‐ Oct 8, 2021 12:15pm

Identification: A-11


Structural Heart – Non-Surgical Interventions

Oct 8, 2021 12:15pm ‐ Oct 8, 2021 12:45pm

Identification: A-12

Learning Objective:
  • 1. The participant will be able to identify the appropriate candidate for Mitral Clip, TAVR or Tricuspid clip, along with the studies involved in making the decision. 2. The participant will recognize the care needed following a structural heart procedure.

Workup for Advanced Therapy

Oct 8, 2021 12:45pm ‐ Oct 8, 2021 1:15pm

Identification: A-13

Learning Objective:
  • 1. Discuss components and diagnostic work-up for advanced heart failure therapies 2. Review the key healthcare providers and their roles in evaluating patients for advanced HF therapies